NanoGroup S.A. has submitted an application for funding from the European Funds for Modern Economy (FENG) program under the Smart path, which concerns the development of an innovative fluid for organ perfusion. The new formula will significantly improve the effectiveness of the perfusion process, opening up new perspectives in the field of transplantology.
The NanOX system, a unique solution in the field of organ perfusion, is in an advanced phase of development. The entire project includes, among others, GMP standard tests and preclinical tests on an animal model and clinical tests to the stage of certification of the solution and readiness to introduce it to the market.
NanoGroup finances all research work from its own funds, while actively seeking additional support, including the EU FENG program. The funds obtained will allow the company to reduce its own contribution and direct part of its own funds to the development of further research projects.
What is the Smart Path in the FENG Competition?
The Smart Path is a program aimed at companies that focus on development through innovation and scientific research. The funding enables companies from the micro, small and medium-sized enterprise sector to implement ambitious research and development projects and implement innovative technologies.
The FENG programme, with a budget of PLN 2.112 billion, is a key European support instrument for companies that strive to increase innovation and introduce new technologies to the market.